1 documents found
Head: Lytvynenko Nataliia V.. Phase III study aims to study the efficacy of ublituximab in treating multiple sclerosis (ULTIMATE study).
Ukrainian medical stomatological Academy. № 0119U102900
1 documents found
Updated: 2026-03-18
